{"id":10123,"date":"2025-07-31T23:29:48","date_gmt":"2025-07-31T20:29:48","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?p=10123"},"modified":"2025-07-31T23:29:48","modified_gmt":"2025-07-31T20:29:48","slug":"norvasc-yan-etkileri","status":"publish","type":"post","link":"https:\/\/www.ortaakarsu.net\/?p=10123","title":{"rendered":"Norvasc Yan\u202fEtkileri"},"content":{"rendered":"

Norvasc\u00ae (amlodipin), kalsiyum kanal blokeri grubunda yer alan, hipertansiyon ve kronik angina tedavisinde yayg\u0131n kullan\u0131lan bir ila\u00e7t\u0131r. T\u00fcrkiye\u2019de antihipertansifler i\u00e7inde re\u00e7ete hacmi y\u00fcksek oldu\u011fundan \u201cNorvasc yan etkileri\u201d aramalar\u0131 da yo\u011funla\u015fm\u0131\u015ft\u0131r. En s\u0131k g\u00f6r\u00fclen etki ayak\u2011bile\u011fi \u00f6demidir; ba\u015f a\u011fr\u0131s\u0131, ba\u015f d\u00f6nmesi, k\u0131zar\u0131kl\u0131k ve \u00e7arp\u0131nt\u0131\u202fda izlenebilir. Yan etkiler \u00e7o\u011fu hastada hafif olsa da, do\u011fru doz, d\u00fczenli takip ve ya\u015fam tarz\u0131 \u00f6nlemleriyle riskler \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131labilir.<\/p>\n<\/div>

En\u202fYayg\u0131n 5\u202fYan\u202fEtki (Prospekt\u00fcs\u202fverisi)<\/h2>\n
\n
\n\n\n\n\n\n\n\n\n\n\n
S\u0131kl\u0131k<\/th>\nYan\u202fEtki<\/th>\nNeden \u00d6nemli?<\/th>\n<\/tr>\n<\/thead>\n
%1\u201110<\/strong><\/td>\nPeriferik \u00f6dem (ayak \u015fi\u015fmesi)<\/strong><\/td>\n\u0130lac\u0131n damar d\u00fcz\u202fkas\u0131n\u0131 gev\u015fetmesi, ven\u00f6z bas\u0131nc\u0131 art\u0131r\u0131r. DergiPark<\/span><\/span><\/span><\/a> <\/span><\/span>Verywell Health<\/span><\/span><\/span><\/a><\/span><\/span><\/td>\n<\/tr>\n
%1\u201110<\/td>\nBa\u015f\u202fa\u011fr\u0131s\u0131<\/td>\nDamar geni\u015flemesine sekonder<\/td>\n<\/tr>\n
%1\u201110<\/td>\nBa\u015f\u202fd\u00f6nmesi<\/td>\nVazodilatasyona ba\u011fl\u0131 ge\u00e7ici hipotansiyon<\/td>\n<\/tr>\n
%0,1\u20111<\/td>\nY\u00fcz\/k\u0131zar\u0131kl\u0131k<\/td>\nCilt damar geni\u015flemesi<\/td>\n<\/tr>\n
%0,1\u20111<\/td>\n\u00c7arp\u0131nt\u0131<\/td>\nRefleks ta\u015fikardi<\/td>\n<\/tr>\n
(Prospekt\u00fcs ve FDA etiketinde doz\u2011ili\u015fkili oranlar da belirtilmi\u015f: \u00f6dem 10\u202fmg\u2019da\u202f%10,8\u2019e \u00e7\u0131k\u0131yor.<\/a>)<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>
<\/span><\/div>

Riskli\u202fHasta\u202fProfilleri<\/h2>\n